Table 1.
Characteristics | Men (N=45 640) | Women (N=36 302) | P value |
---|---|---|---|
Age, mean (SD), y | 59.85 (17.85) | 62.58 (19.62) | <0.001 |
Elective admission | 15.17% | 15.93% | 0.003 |
Organisms/microbiology | |||
Staphylococcus aureus endocarditis | 27.92% | 26.04% | <0.001 |
Streptococcus endocarditis | 27.66% | 17.99% | <0.001 |
Gram‐negative endocarditis | 7.69% | 4.84% | <0.001 |
Enterococcus endocarditis | 4.03% | 3.18% | <0.001 |
Fungus endocarditis | 0.82% | 0.67% | 0.02 |
Unknown organism | 19.6% | 28.2% | <0.001 |
Risk factors and comorbidities | |||
Drug abuse | 19.73% | 15.54% | <0.001 |
Congenital heart disease | 5.22% | 3.16% | <0.001 |
Hepatitis C | 12.69% | 11.39% | <0.001 |
Chronic rheumatic heart disease | 8.83% | 9.16% | 0.099 |
Infection of cardiac device/implant (prosthetic valve endocarditis) | 9.02% | 5.01% | <0.001 |
Prior valve replacement | 7.00% | 5.32% | <0.001 |
Prior PCI | 2.58% | 1.94% | <0.001 |
Prior CABG | 6.73% | 3.68% | <0.001 |
Congestive heart failure | 32.75% | 32.09% | 0.046 |
Cardiac arrhythmias | 34.26% | 31.84% | <0.001 |
Atrial fibrillation | 21.13% | 20.40% | 0.009 |
Coronary artery disease | 23.05% | 18.61% | <0.001 |
Liver cirrhosis | 3.75% | 2.34% | <0.001 |
Coagulopathy | 11.85% | 9.55% | <0.001 |
Diabetes controlled | 16.48% | 18.12% | <0.001 |
Diabetes uncontrolled | 5.58% | 5.62% | 0.91 |
Hypertension controlled | 29.27% | 33.51% | <0.001 |
Hypertension uncontrolled | 18.55% | 17.90% | 0.018 |
Peripheral vascular disease | 6.46% | 5.64% | <0.001 |
Smoking | 6.16% | 3.97% | <0.001 |
Solid tumor without metastasis | 2.91% | 2.41% | <0.001 |
Metastatic cancer | 1.29% | 1.28% | 0.98 |
Malnutrition disorder | 7.47% | 7.47% | 0.99 |
Cardiogenic shock | 1.72% | 1.08% | <0.001 |
Myocardial infarction | 3.95% | 3.50% | 0.005 |
Mechanical ventilation | 3.64% | 3.36% | 0.035 |
Blood transfusion | 17.67% | 17.62% | 0.86 |
Demographics | |||
Race/ethnicity | |||
White | 74.05% | 73.50% | <0.001* |
Black | 12.72% | 14.60% | |
Hispanic | 8.09% | 6.81% | |
Hospital bed size | |||
Small | 13.98% | 15.39% | <0.001 |
Medium | 23.21% | 24.56% | |
Large | 62.80% | 60.05% | |
Hospital region | |||
Northeast | 22.90% | 21.68% | <0.001 |
Midwest | 20.21% | 21.23% | |
South | 38.76% | 41.30% | |
West | 18.12% | 15.76% |
CABG indicates coronary artery bypass graft; and PCI, percutaneous coronary intervention.
P value applies to all three races.